Citation Impact
Citing Papers
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study
2000
Transthyretin: a multifaceted protein
2014
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
2009
Identification and Importance of Brown Adipose Tissue in Adult Humans
2009 Standout
Relationship of the tumor necrosis factor-α −308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus
2002
Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study
2002
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
2009 Standout
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction
2001
The metabolic syndrome
2010 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
2004 Standout
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
2004 Standout
The Continuing Epidemics of Obesity and Diabetes in the United States
2001 Standout
Exendin‐4, a glucagon‐like protein‐1 (GLP‐1) receptor agonist, reverses hepatic steatosis in ob/ob mice†
2005
Self‐Reported Body Mass Index and Health‐Related Quality of Life: Findings from the Behavioral Risk Factor Surveillance System
2001
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
2002
Esophageal Cancer
2003 Standout
Exclusive Action of Transmembrane TNFα in Adipose Tissue Leads to Reduced Adipose Mass and Local But Not Systemic Insulin Resistance
2002
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
2003 Standout
Association of the TNF‐α−308 G/A Promoter Polymorphism with Insulin Resistance in Obesity
2002
A prospective study of obesity and cancer risk (Sweden)
2001
The Arthritis, Diet and Activity Promotion Trial (ADAPT): design, rationale, and baseline results
2003
Inflammation, stress, and diabetes
2005 Standout
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 Standout
Role of Tumor Necrosis Factor–α and Interleukin‐10 Promoter Gene Polymorphisms in Leprosy
2002
The metabolic syndrome
2005 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
2011
Oesophageal carcinoma
2013 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Obesity Correlates with Gastroesophageal Reflux
1999
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
2004 Standout
Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus
2002
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
The weirdest people in the world?
2010 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Leprosy
2004 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Gastric cancer
2020 Standout
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones
2003
Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma
2003
The Human Obesity Gene Map: The 2001 Update
2002
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
What We Talk About When We Talk About Fat
2014 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
The Human Obesity Gene Map: The 2003 Update
2004
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
2004
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Tumour necrosis factor‐α in human adipose tissue – from signalling mechanisms to clinical implications
2007
Additional protein intake limits weight regain after weight loss in humans
2005
Hepatocellular Carcinoma
2011 Standout
Incretins, insulin secretion and Type 2 diabetes mellitus
2004
Prediabetes: a high-risk state for diabetes development
2012 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes
2006
Gastroesophageal Reflux Disease
1996
Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Gene Locus
2002
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Waist–hip ratio and attractiveness New evidence and a critique of “a critical test”
2003
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects
2002
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
2001
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
2003
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Pharmacological Approaches for the Treatment of Obesity
2002
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans
2001
Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211)
2004
Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications
2005
Ceramide Mediates Insulin Resistance by Tumor Necrosis Factor-α in Brown Adipocytes by Maintaining Akt in an Inactive Dephosphorylated State
2001
Local, exendin-(9—39)-insensitive, site of action of GLP-1 in canine ileum
2002
Incretin hormones - an update
2001
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
1999
Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects
1985
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators
2003 Standout
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Weight loss maintenance.
2010
Obesity and chronic kidney disease
2022
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
2005
Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain
2001
The Glucagon-Like Peptides
1999
Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man
1984
Describing the Weight‐Reduced State: Physiology, Behavior, and Interventions
2021
Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs
2003
Mechanism of action of gemfibrozil on lipoprotein metabolism.
1985
Gut hormone PYY3-36 physiologically inhibits food intake
2002 StandoutNature
Diet or exercise, or both, for weight reduction in women after childbirth
2013
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
1987
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
2001
Works of S Rössner being referenced
Long term propranolol treatment and changes in body weight after myocardial infarction.
1990
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
1999
Excessive fat accumulation is associated with the TNFα -308 G/A promoter polymorphism in women but not in men
2000
An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer
1997
Topiramate in the treatment of obese subjects with drug‐naive type 2 diabetes
2006
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial
2001
Gastroesophageal Reflux in Obese Patients Is Not Reduced by Weight Reduction
1996
Transthyretin constitutes a functional component in pancreatic β-cell stimulus-secretion coupling
2005
Obesity and self-perceived health in Sweden.
1996
Pregnancy, weight cycling and weight gain in obesity.
1992
Effect of Gemfibrozil on Lipoprotein Concentrations in Different Types of Hyperlipoproteinæmia
1976
Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue.
2000